+Follow
SnorlaxSnore
No personal profile
5
Follow
1
Followers
0
Topic
0
Badge
Posts
Hot
SnorlaxSnore
2022-05-29
Hm 🤔
Sorry, the original content has been removed
SnorlaxSnore
2022-04-20
👍
Sorry, the original content has been removed
SnorlaxSnore
2022-04-02
Nice
Sorry, the original content has been removed
SnorlaxSnore
2021-12-30
Cool
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4102746465686220","uuid":"4102746465686220","gmtCreate":1640050617557,"gmtModify":1643213188033,"name":"SnorlaxSnore","pinyin":"snorlaxsnore","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.05.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9024837395,"gmtCreate":1653837582117,"gmtModify":1676535349199,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"Hm 🤔 ","listText":"Hm 🤔 ","text":"Hm 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9024837395","repostId":"2238953846","repostType":4,"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9086175318,"gmtCreate":1650426825956,"gmtModify":1676534722461,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086175318","repostId":"1184676929","repostType":4,"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9011154445,"gmtCreate":1648835605793,"gmtModify":1676534407788,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9011154445","repostId":"1187810620","repostType":4,"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003044799,"gmtCreate":1640832682110,"gmtModify":1676533546198,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003044799","repostId":"1158401825","repostType":4,"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9024837395,"gmtCreate":1653837582117,"gmtModify":1676535349199,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"Hm 🤔 ","listText":"Hm 🤔 ","text":"Hm 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9024837395","repostId":"2238953846","repostType":4,"repost":{"id":"2238953846","kind":"highlight","pubTimestamp":1653811796,"share":"https://ttm.financial/m/news/2238953846?lang=&edition=fundamental","pubTime":"2022-05-29 16:09","market":"us","language":"en","title":"3 Stocks That Could Easily Turn $10,000 Into $50,000 by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2238953846","media":"Motley Fool","summary":"A 5x return isn't a slam dunk with these stocks. But it's not a farfetched proposition.","content":"<html><head></head><body><p>Quintupling just has a nice ring to it. There's not an investor around who wouldn't like to see their money grow by five times or more.</p><p>Finding stocks that can achieve the goal is easier said than done, though. That's especially the case if you're wanting huge gains within only a few years. But it's not impossible to find promising candidates. Here are three stocks that could easily turn $10,000 into $50,000 by 2030.</p><h2>1. <a href=\"https://laohu8.com/S/TDOC\">Teladoc Health</a></h2><p><a href=\"https://laohu8.com/S/TDOC\">Teladoc Health</a> could deliver a 5x return simply by returning to where its shares traded less than a year ago. Since last summer, the telemedicine stock has plunged close to 80%.</p><p>Of course, getting back to those levels isn't so simple. Teladoc must first convince investors that it's able to deliver strong revenue growth and achieve profitability. I think the company has a good shot at doing both. Despite a huge net loss and reducing its full-year guidance for 2022, Teladoc's business actually appears to be in pretty good shape.</p><p>That big loss was due to a goodwill impairment primarily related to the acquisition of Livongo. Excluding this write-off, the company's bottom line improved year over year. And although Teladoc's full-year outlook is lower than it was previously, it still expects revenue to grow in the ballpark of 20%.</p><p>Teladoc continues to win new customers. It's only in the early stages of rolling out the Primary360 virtual primary care service. The company's addressable market is massive -- over $260 billion in the U.S. alone. Teladoc certainly isn't a slam dunk to quintuple by the end of the decade. However, it isn't too far-fetched a proposition at all.</p><h2>2. <a href=\"https://laohu8.com/S/NVCR\">Novocure</a></h2><p>Turning $10,000 into $50,000 by 2030 could be too pessimistic a goal for <a href=\"https://laohu8.com/S/NVCR\">Novocure</a>. Sure, the stock is down more than 60% since last July as the company's revenue growth has slowed. But Novocure has multiple catalysts on the way.</p><p>The company has already won U.S. regulatory approval for its Tumor Treating Fields (TTFields) device in treating glioblastoma multiforme (an aggressive type of brain cancer) and mesothelioma. However, Novocure thinks that its method of using electric fields to disrupt the division of tumor cells can work in other types of cancer as well.</p><p>Results from a late-stage study of TTFields in treating non-small cell lung cancer should be announced later this year. In 2023, Novocure expects to report data from pivotal studies targeting ovarian cancer and brain metastases. The following year, results from another phase 3 study of TTFields in treating pancreatic cancer should be available.</p><p>Novocure estimates that these additional indications represent a market opportunity that's <i>14 times larger</i> than its current market opportunity in approved indications. If the company's late-stage clinical studies go well, the stock should have a pretty good shot at delivering a 5x return or greater within the next eight years.</p><h2>3. <a href=\"https://laohu8.com/S/MELI\">MercadoLibre</a></h2><p><a href=\"https://laohu8.com/S/MELI\">MercadoLibre</a> is another beaten-down stock that still has tremendous long-term potential. Shares of the Latin American e-commerce leader have dropped close to 60% since the third quarter of 2021. However, MercadoLibre's business continues to perform well.</p><p>The company generated record net revenue in the first quarter of 2022. It posted a small profit, a huge improvement from the net losses in the previous quarter and in the prior-year period.</p><p>More importantly, MercadoLibre is only scratching the surface of its opportunity. E-commerce market penetration rates in Latin America remain low. The company's fintech business has a significant growth runway as well. Many people in the countries served by MercadoLibre have no or limited access to traditional financial services.</p><p>MercadoLibre could also grow by expanding into adjacent markets. Osvaldo Gimenez, CEO of the company's Mercado Pago unit, stated in the Q1 conference call that a pilot of a payroll service is in its early stages. He added, "We're very excited about the opportunity."</p><p>Wall Street's consensus 12-month price target for MercadoLibre is nearly double its current share price. I think that the company's growth potential in e-commerce, fintech, and new businesses just might enable the stock to turn an initial investment of $10,000 into $50,000 by 2030.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Could Easily Turn $10,000 Into $50,000 by 2030</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Could Easily Turn $10,000 Into $50,000 by 2030\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-29 16:09 GMT+8 <a href=https://www.fool.com/investing/2022/05/28/3-stocks-that-could-easily-turn-10000-into-50000-b/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Quintupling just has a nice ring to it. There's not an investor around who wouldn't like to see their money grow by five times or more.Finding stocks that can achieve the goal is easier said than done...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/28/3-stocks-that-could-easily-turn-10000-into-50000-b/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4122":"互联网与直销零售","QNETCN":"纳斯达克中美互联网老虎指数","BK4548":"巴美列捷福持仓","BK4167":"医疗保健技术","MELI":"MercadoLibre","TDOC":"Teladoc Health Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4581":"高盛持仓","BK4504":"桥水持仓","BK4566":"资本集团"},"source_url":"https://www.fool.com/investing/2022/05/28/3-stocks-that-could-easily-turn-10000-into-50000-b/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2238953846","content_text":"Quintupling just has a nice ring to it. There's not an investor around who wouldn't like to see their money grow by five times or more.Finding stocks that can achieve the goal is easier said than done, though. That's especially the case if you're wanting huge gains within only a few years. But it's not impossible to find promising candidates. Here are three stocks that could easily turn $10,000 into $50,000 by 2030.1. Teladoc HealthTeladoc Health could deliver a 5x return simply by returning to where its shares traded less than a year ago. Since last summer, the telemedicine stock has plunged close to 80%.Of course, getting back to those levels isn't so simple. Teladoc must first convince investors that it's able to deliver strong revenue growth and achieve profitability. I think the company has a good shot at doing both. Despite a huge net loss and reducing its full-year guidance for 2022, Teladoc's business actually appears to be in pretty good shape.That big loss was due to a goodwill impairment primarily related to the acquisition of Livongo. Excluding this write-off, the company's bottom line improved year over year. And although Teladoc's full-year outlook is lower than it was previously, it still expects revenue to grow in the ballpark of 20%.Teladoc continues to win new customers. It's only in the early stages of rolling out the Primary360 virtual primary care service. The company's addressable market is massive -- over $260 billion in the U.S. alone. Teladoc certainly isn't a slam dunk to quintuple by the end of the decade. However, it isn't too far-fetched a proposition at all.2. NovocureTurning $10,000 into $50,000 by 2030 could be too pessimistic a goal for Novocure. Sure, the stock is down more than 60% since last July as the company's revenue growth has slowed. But Novocure has multiple catalysts on the way.The company has already won U.S. regulatory approval for its Tumor Treating Fields (TTFields) device in treating glioblastoma multiforme (an aggressive type of brain cancer) and mesothelioma. However, Novocure thinks that its method of using electric fields to disrupt the division of tumor cells can work in other types of cancer as well.Results from a late-stage study of TTFields in treating non-small cell lung cancer should be announced later this year. In 2023, Novocure expects to report data from pivotal studies targeting ovarian cancer and brain metastases. The following year, results from another phase 3 study of TTFields in treating pancreatic cancer should be available.Novocure estimates that these additional indications represent a market opportunity that's 14 times larger than its current market opportunity in approved indications. If the company's late-stage clinical studies go well, the stock should have a pretty good shot at delivering a 5x return or greater within the next eight years.3. MercadoLibreMercadoLibre is another beaten-down stock that still has tremendous long-term potential. Shares of the Latin American e-commerce leader have dropped close to 60% since the third quarter of 2021. However, MercadoLibre's business continues to perform well.The company generated record net revenue in the first quarter of 2022. It posted a small profit, a huge improvement from the net losses in the previous quarter and in the prior-year period.More importantly, MercadoLibre is only scratching the surface of its opportunity. E-commerce market penetration rates in Latin America remain low. The company's fintech business has a significant growth runway as well. Many people in the countries served by MercadoLibre have no or limited access to traditional financial services.MercadoLibre could also grow by expanding into adjacent markets. Osvaldo Gimenez, CEO of the company's Mercado Pago unit, stated in the Q1 conference call that a pilot of a payroll service is in its early stages. He added, \"We're very excited about the opportunity.\"Wall Street's consensus 12-month price target for MercadoLibre is nearly double its current share price. I think that the company's growth potential in e-commerce, fintech, and new businesses just might enable the stock to turn an initial investment of $10,000 into $50,000 by 2030.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003044799,"gmtCreate":1640832682110,"gmtModify":1676533546198,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003044799","repostId":"1158401825","repostType":4,"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9011154445,"gmtCreate":1648835605793,"gmtModify":1676534407788,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9011154445","repostId":"1187810620","repostType":4,"repost":{"id":"1187810620","kind":"news","pubTimestamp":1648804203,"share":"https://ttm.financial/m/news/1187810620?lang=&edition=fundamental","pubTime":"2022-04-01 17:10","market":"us","language":"en","title":"Palantir: Green Shoots","url":"https://stock-news.laohu8.com/highlight/detail?id=1187810620","media":"seekingalpha","summary":"SummaryPLTR continues to perform poorly against the market.The Quant view and Wall Street analysts a","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>PLTR continues to perform poorly against the market.</li><li>The Quant view and Wall Street analysts are not currently optimistic.</li><li>However, PLTR continues to grow at 30-40%, with little to stop it.</li><li>Further, PLTR is not burdened by debt and will not go bankrupt.</li><li>Early 2022 still doesn't look great, but H2 2022 could improve.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c90b965827628dbf75245094b21ea264\" tg-width=\"1536\" tg-height=\"1025\" width=\"100%\" height=\"auto\"/><span>amenic181/iStock via Getty Images</span></p><p>On January 13th, I wrote Palantir: Dark Days. I said that I was bullish on Palantir (NYSE:PLTR), but I also added some melancholy notes:</p><blockquote>Unfortunately, the price action has been terrible for most growthstocks and the macro environment doesn't look favorable for PLTR in H1 2022. Unless there is some kind of huge announcement, or SBC drops precipitously, PLTR is most likely going to remain well under $25. In fact, it will likely languish in the $18-22 range in H1 2022, given what we know what right.</blockquote><p>Back in the middle of January, PLTR was down about 8% year-to-date. Well, here's how that looks now:</p><p><img src=\"https://static.tigerbbs.com/d18c3521aa35ce577d677c2d059dd81e\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"/></p><p>Yes, we're down 24% from January 1st through today. In terms of price action, perhaps the only good news is that PLTR isn't down 40-45% this year.</p><p>The quantitative view continues to be ugly:</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/71648c1529993d1254b5b08a45b35ce3\" tg-width=\"640\" tg-height=\"196\" width=\"100%\" height=\"auto\"/><span>PLTR QUANT RATINGS (Seeking Alpha)</span></p><p>Wall Street is mostly neutral with an overall "Hold" rating.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f4252374698b0888c2e474a2f5a1c0bc\" tg-width=\"640\" tg-height=\"388\" width=\"100%\" height=\"auto\"/><span>WALL STREET on PLTR (Seeking Alpha)</span></p><p>All of this said, I think it's fair to say that nearly all the indicators are flat, or they are pointing down.PLTR is still in the dark days.</p><p><b>Some Quick Comparisons</b></p><p>It's often a good idea to think about a company in relation to some peers, and the market as a whole. While I don't believe that PLTR has direct competition,except for the government itself, I do think that overall pressure on growth stocks is worth considering.</p><p><img src=\"https://static.tigerbbs.com/ca1b20ba7b1ea83876fab60fbd081829\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"/></p><p>Here's some bad news. One year ago, PLTR was moving up and down in price faster than the Nasdaq 100 Index (QQQ). That is, we were seeing far more volatility, but at least PLTR was roughly tracking the index. However, in November of 2021,<i>PLTR started to fall off a cliff</i>. Clearly, the QQQ also declined, but the drop was far worse for PLTR, into 2022.</p><p>It's worth digging into the greater than average market pain.</p><p><b>Relentless Downward Pressure on Growth</b></p><p>Although PLTR has a market cap of just under $30 billion, it's still relatively small, and more prone to violent moves up and down. But, the real kicker is that PLTR is an aggressive growth stock. That's what investors wanted, and that's what it delivered. But, the macro environment changed and what I'll call the "Growth Leverage" is now working strongly against PLTR.</p><p>Here's a hint, from the <i>New York Times</i>, back in November 2021.</p><blockquote>The Fed has been buying $120 billion in bonds each month and has kept interest rates near zero, policy moves that have helped make borrowing cheap and keep money flowing through the economy. Earlier this month, the Fed took the first step toward withdrawing support for the economy when it announced that it would begin scaling back its Treasury bond and mortgage-backed security purchases by $15 billion a month starting in November.</blockquote><p>Fast forward about one month, and <i>Bloomberg</i> added:</p><blockquote>The new rate projections marks a major shift from the last time forecasts were updated in September when officials were evenly split on the need for any rate increases at all in 2022. The new projections also showed policy makers see another three increases as appropriate in 2023 and two more in 2024, bringing the funds rate to 2.1% by the end of that year.</blockquote><p>Adding it up, the short-term outlook is quite negative. Indeed, depending on your definition, the medium-term outlook is equally negative. Dare I say that I'm bearish in Q2 2022? That doesn't mean I'm screaming "SELL" from the top of my lungs. Instead, as I'll explain below, it's more like my expectations are modest, until H2 2022.</p><p><b>Some "Green Shoots"</b></p><p>I largely agree with <i>Forbes</i> on these points:</p><blockquote>... Palantir further sees its revenues growing at levels of over 30% each year between 2021 through 2025. The longer-term opportunity also looks solid. The company’s artificial intelligence (AI) software tools are trusted by the U.S. government and these technologies are becoming increasingly valuable in the commercial space as well, as AI plays a greater role in the economy.</blockquote><p>I believe that PLTR will continue to see 30% or higher revenue growth over the next 2-3 years. And, I see artificial intelligence spending to ramp up. NVIDIA (NVDA) CEO Jensen Huang broke it down like this:</p><ul><li>$300 billion in sales to the auto industry.</li><li>$300 billion in chips and systems.</li><li>$300 billion in enterprise software.</li><li>$100 billion in the video game industry.</li></ul><p>That's one trillion dollars. And, for each industry, there's a true, deep need for data analytics, data management, strategic decision making, and far more. That's where PLTR fits in, and that's mostly in the commercial space. We know that PLTR is very strong in government, of course.From the Q4 2021 report:</p><p><b>Government revenue growth year-over-year</b>:</p><ul><li>Q1 2021 = 76%</li><li>Q2 2021 = 66%</li><li>Q3 2021 = 34%</li><li>Q4 2021 = 26%</li></ul><p>And, for good measure...</p><p><b>US commercial revenue growth year-over-year</b>:</p><ul><li>Q1 2021 = 72%</li><li>Q2 2021 = 90%</li><li>Q3 2021 = 103%</li><li>Q4 2021 = 132%</li></ul><p>For both segments, customer value is up, customer count is up, and more. Gross margins are over 80%. Operating margins are stable. PLTR is still working through post-DPO issues, such as the stock-based compensation. As I explained last year,it'll work out just fine, just slower than investors want.</p><p>As a relevant aside, the Q4 2021 earnings report that dropped in February 2022 wasn't exactly wonderful:Non-GAAP was $0.02 but missed by $0.02. Revenue is expected to be above consensus in Q1 2022 at least. We'll see.</p><p>The point is that there's stability or growth in nearly all parts of the business. It's not a perfectly running machine but it's a strong company. And, as I like to point out, it's not going bankrupt because of this:</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1ee9f32b0c891c5e117cd540905c0cdc\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"/><span>No debt problems.</span></p><p><b>"Green Shoots" Part 2</b></p><p>So, investors are generally aware of PLTR's customer growth. But, it's useful to consider the other financial metrics of growth.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc62952017b8f0a79a45a288e733955\" tg-width=\"640\" tg-height=\"568\" width=\"100%\" height=\"auto\"/><span>Financial Green Shoots for PLTR (Seeking Alpha)</span></p><p>It's all there, in plain view. Clearly, revenue is growing like crazy, even when compared to the Sector. And, both EBITDA Growth and EBIT Growth are crushing the Sector Median; very healthy. Looking forward, EPS forward growth is also outstanding. Even Working Capital is in good shape, which I see as just another buffer against a weak environment for growth.</p><p>I also encourage investors to look here:</p><ul><li>Gross Profit Margin is higher than the Sector Median</li><li>Levered FCF Margin is higher than the Sector Median</li><li>Cash from Operations is higher than the Sector Median</li></ul><p>All of this indicates to me that true profits are coming, <i>just not in Q2 2022</i>.</p><p><b>Wrap Up</b></p><p>We're stuck right now because of valuation, stock price, SBC, missing Wall Street expectations in Q4 2021, and the macro environment. The big picture is that PLTR is rightfully suppressed. But, digging into the details, it's also true that PLTR is a growth machine with a bright future.</p><p>Summing it all up, I can say this: I'm not selling PLTR. I'll continue to hold. Or, said differently, I'm neutral about PLTR in the short run, but bullish in the long run. Now is not a bad time to accumulate, or to start a position. Dollar-cost averaging, or dripping, is equally rational for some investors.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir: Green Shoots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir: Green Shoots\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-01 17:10 GMT+8 <a href=https://seekingalpha.com/article/4499129-palantir-stock-could-improve-h2-2022><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryPLTR continues to perform poorly against the market.The Quant view and Wall Street analysts are not currently optimistic.However, PLTR continues to grow at 30-40%, with little to stop it....</p>\n\n<a href=\"https://seekingalpha.com/article/4499129-palantir-stock-could-improve-h2-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4499129-palantir-stock-could-improve-h2-2022","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1187810620","content_text":"SummaryPLTR continues to perform poorly against the market.The Quant view and Wall Street analysts are not currently optimistic.However, PLTR continues to grow at 30-40%, with little to stop it.Further, PLTR is not burdened by debt and will not go bankrupt.Early 2022 still doesn't look great, but H2 2022 could improve.amenic181/iStock via Getty ImagesOn January 13th, I wrote Palantir: Dark Days. I said that I was bullish on Palantir (NYSE:PLTR), but I also added some melancholy notes:Unfortunately, the price action has been terrible for most growthstocks and the macro environment doesn't look favorable for PLTR in H1 2022. Unless there is some kind of huge announcement, or SBC drops precipitously, PLTR is most likely going to remain well under $25. In fact, it will likely languish in the $18-22 range in H1 2022, given what we know what right.Back in the middle of January, PLTR was down about 8% year-to-date. Well, here's how that looks now:Yes, we're down 24% from January 1st through today. In terms of price action, perhaps the only good news is that PLTR isn't down 40-45% this year.The quantitative view continues to be ugly:PLTR QUANT RATINGS (Seeking Alpha)Wall Street is mostly neutral with an overall \"Hold\" rating.WALL STREET on PLTR (Seeking Alpha)All of this said, I think it's fair to say that nearly all the indicators are flat, or they are pointing down.PLTR is still in the dark days.Some Quick ComparisonsIt's often a good idea to think about a company in relation to some peers, and the market as a whole. While I don't believe that PLTR has direct competition,except for the government itself, I do think that overall pressure on growth stocks is worth considering.Here's some bad news. One year ago, PLTR was moving up and down in price faster than the Nasdaq 100 Index (QQQ). That is, we were seeing far more volatility, but at least PLTR was roughly tracking the index. However, in November of 2021,PLTR started to fall off a cliff. Clearly, the QQQ also declined, but the drop was far worse for PLTR, into 2022.It's worth digging into the greater than average market pain.Relentless Downward Pressure on GrowthAlthough PLTR has a market cap of just under $30 billion, it's still relatively small, and more prone to violent moves up and down. But, the real kicker is that PLTR is an aggressive growth stock. That's what investors wanted, and that's what it delivered. But, the macro environment changed and what I'll call the \"Growth Leverage\" is now working strongly against PLTR.Here's a hint, from the New York Times, back in November 2021.The Fed has been buying $120 billion in bonds each month and has kept interest rates near zero, policy moves that have helped make borrowing cheap and keep money flowing through the economy. Earlier this month, the Fed took the first step toward withdrawing support for the economy when it announced that it would begin scaling back its Treasury bond and mortgage-backed security purchases by $15 billion a month starting in November.Fast forward about one month, and Bloomberg added:The new rate projections marks a major shift from the last time forecasts were updated in September when officials were evenly split on the need for any rate increases at all in 2022. The new projections also showed policy makers see another three increases as appropriate in 2023 and two more in 2024, bringing the funds rate to 2.1% by the end of that year.Adding it up, the short-term outlook is quite negative. Indeed, depending on your definition, the medium-term outlook is equally negative. Dare I say that I'm bearish in Q2 2022? That doesn't mean I'm screaming \"SELL\" from the top of my lungs. Instead, as I'll explain below, it's more like my expectations are modest, until H2 2022.Some \"Green Shoots\"I largely agree with Forbes on these points:... Palantir further sees its revenues growing at levels of over 30% each year between 2021 through 2025. The longer-term opportunity also looks solid. The company’s artificial intelligence (AI) software tools are trusted by the U.S. government and these technologies are becoming increasingly valuable in the commercial space as well, as AI plays a greater role in the economy.I believe that PLTR will continue to see 30% or higher revenue growth over the next 2-3 years. And, I see artificial intelligence spending to ramp up. NVIDIA (NVDA) CEO Jensen Huang broke it down like this:$300 billion in sales to the auto industry.$300 billion in chips and systems.$300 billion in enterprise software.$100 billion in the video game industry.That's one trillion dollars. And, for each industry, there's a true, deep need for data analytics, data management, strategic decision making, and far more. That's where PLTR fits in, and that's mostly in the commercial space. We know that PLTR is very strong in government, of course.From the Q4 2021 report:Government revenue growth year-over-year:Q1 2021 = 76%Q2 2021 = 66%Q3 2021 = 34%Q4 2021 = 26%And, for good measure...US commercial revenue growth year-over-year:Q1 2021 = 72%Q2 2021 = 90%Q3 2021 = 103%Q4 2021 = 132%For both segments, customer value is up, customer count is up, and more. Gross margins are over 80%. Operating margins are stable. PLTR is still working through post-DPO issues, such as the stock-based compensation. As I explained last year,it'll work out just fine, just slower than investors want.As a relevant aside, the Q4 2021 earnings report that dropped in February 2022 wasn't exactly wonderful:Non-GAAP was $0.02 but missed by $0.02. Revenue is expected to be above consensus in Q1 2022 at least. We'll see.The point is that there's stability or growth in nearly all parts of the business. It's not a perfectly running machine but it's a strong company. And, as I like to point out, it's not going bankrupt because of this:No debt problems.\"Green Shoots\" Part 2So, investors are generally aware of PLTR's customer growth. But, it's useful to consider the other financial metrics of growth.Financial Green Shoots for PLTR (Seeking Alpha)It's all there, in plain view. Clearly, revenue is growing like crazy, even when compared to the Sector. And, both EBITDA Growth and EBIT Growth are crushing the Sector Median; very healthy. Looking forward, EPS forward growth is also outstanding. Even Working Capital is in good shape, which I see as just another buffer against a weak environment for growth.I also encourage investors to look here:Gross Profit Margin is higher than the Sector MedianLevered FCF Margin is higher than the Sector MedianCash from Operations is higher than the Sector MedianAll of this indicates to me that true profits are coming, just not in Q2 2022.Wrap UpWe're stuck right now because of valuation, stock price, SBC, missing Wall Street expectations in Q4 2021, and the macro environment. The big picture is that PLTR is rightfully suppressed. But, digging into the details, it's also true that PLTR is a growth machine with a bright future.Summing it all up, I can say this: I'm not selling PLTR. I'll continue to hold. Or, said differently, I'm neutral about PLTR in the short run, but bullish in the long run. Now is not a bad time to accumulate, or to start a position. Dollar-cost averaging, or dripping, is equally rational for some investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9086175318,"gmtCreate":1650426825956,"gmtModify":1676534722461,"author":{"id":"4102746465686220","authorId":"4102746465686220","name":"SnorlaxSnore","avatar":"https://static.itradeup.com/news/293f8e3f506cc5f15ebb8480303bfe14","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102746465686220","authorIdStr":"4102746465686220"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086175318","repostId":"1184676929","repostType":4,"repost":{"id":"1184676929","kind":"news","pubTimestamp":1650413180,"share":"https://ttm.financial/m/news/1184676929?lang=&edition=fundamental","pubTime":"2022-04-20 08:06","market":"sg","language":"en","title":"Singapore Stock Market May Extend Tuesday's Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1184676929","media":"RTTNews","summary":"The Singapore stock market on Tuesday ended the two-day losing streak in which it had stumbled almos","content":"<html><head></head><body><p>The Singapore stock market on Tuesday ended the two-day losing streak in which it had stumbled almost 45 points or 1.3 percent. The Straits Times Index now rests just above the 3,305-point plateau and it's expected to open in the green again on Wednesday.</p><p>The global forecast for the Asian markets is upbeat on continued optimism for earnings. The European markets were down and the U.S. bourses were up and now tech shares are expected to lead the Asian markets higher.</p><p>The STI finished slightly higher on Tuesday following missed performances from the financial shares, property stocks and industrials.</p><p>For the day, the index perked 4.06 points or 0.12 percent to finish at 3,307.13 after trading between 3,307.13 and 3,344.66. Volume was 2 billion shares worth 1.2 billion Singapore dollars. There were 244 decliners and 211 gainers.</p><p>Among the actives, Ascendas REIT was down 0.35 percent, while CapitaLand Investment sank 0.75 percent, City Developments jumped 0.73 percent, Comfort DelGro improved 0.67 percent, Dairy Farm International rose 0.36 percent, Fraser Logistics shed 0.69 percent, Hongkong Land soared 0.84 percent, Keppel Corp spiked 0.76 percent, Mapletree Commercial Trust lost 0.53 percent, Mapletree Industrial Trust slid 0.37 percent, Oversea-Chinese Banking Corporation fell 0.50 percent, SATS eased 0.23 percent, SembCorp Industries surged 3.82 percent, Singapore Airlines rallied 0.74 percent, Singapore Exchange advanced 0.61 percent, Singapore Technologies Engineering and United Overseas Bank both gained 0.50 percent, Thai Beverage climbed 0.71 percent, Yangzijiang Shipbuilding tumbled 1.84 percent and Wilmar International, Mapletree Logistics Trust, Genting Singapore, DBS Group, CapitaLand Integrated Commercial Trust, SingTel and UOL Group were unchanged.</p><p>The lead from Wall Street is broadly positive as the major averages opened higher on Tuesday and picked up steam as the day progressed, ending sharply higher.</p><p>The Dow surged 499.51 points or 1.45 percent to finish at 34,911.20, while the NASDAQ soared 287.30 points or 2.15 percent to end at 13,619.66 and the S&P 500 jumped 70.52 points or 1.61 percent to close at 4,462.21.</p><p>The rally on Wall Street reflected largely upbeat earnings news from companies like Hasbro (HAS) and Johnson & Johnson (JNJ), although insurance giant Travelers (TRV) moved sharply lower despite earnings that beat estimates.</p><p>In U.S. economic news, the Commerce Department said new residential construction saw modest growth in March, while building permits also unexpectedly bounced higher.</p><p>Crude oil prices fell sharply Tuesday on concerns about outlook for energy demand following a downward revision in global growth forecast by the International Monetary Fund. West Texas Intermediate Crude oil futures for May ended down by $5.65 or 5.2 percent at $102.56 a barrel.</p></body></html>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market May Extend Tuesday's Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market May Extend Tuesday's Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-04-20 08:06 GMT+8 <a href=https://www.rttnews.com/3276564/singapore-stock-market-may-extend-tuesday-s-gains.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market on Tuesday ended the two-day losing streak in which it had stumbled almost 45 points or 1.3 percent. The Straits Times Index now rests just above the 3,305-point plateau and...</p>\n\n<a href=\"https://www.rttnews.com/3276564/singapore-stock-market-may-extend-tuesday-s-gains.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3276564/singapore-stock-market-may-extend-tuesday-s-gains.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184676929","content_text":"The Singapore stock market on Tuesday ended the two-day losing streak in which it had stumbled almost 45 points or 1.3 percent. The Straits Times Index now rests just above the 3,305-point plateau and it's expected to open in the green again on Wednesday.The global forecast for the Asian markets is upbeat on continued optimism for earnings. The European markets were down and the U.S. bourses were up and now tech shares are expected to lead the Asian markets higher.The STI finished slightly higher on Tuesday following missed performances from the financial shares, property stocks and industrials.For the day, the index perked 4.06 points or 0.12 percent to finish at 3,307.13 after trading between 3,307.13 and 3,344.66. Volume was 2 billion shares worth 1.2 billion Singapore dollars. There were 244 decliners and 211 gainers.Among the actives, Ascendas REIT was down 0.35 percent, while CapitaLand Investment sank 0.75 percent, City Developments jumped 0.73 percent, Comfort DelGro improved 0.67 percent, Dairy Farm International rose 0.36 percent, Fraser Logistics shed 0.69 percent, Hongkong Land soared 0.84 percent, Keppel Corp spiked 0.76 percent, Mapletree Commercial Trust lost 0.53 percent, Mapletree Industrial Trust slid 0.37 percent, Oversea-Chinese Banking Corporation fell 0.50 percent, SATS eased 0.23 percent, SembCorp Industries surged 3.82 percent, Singapore Airlines rallied 0.74 percent, Singapore Exchange advanced 0.61 percent, Singapore Technologies Engineering and United Overseas Bank both gained 0.50 percent, Thai Beverage climbed 0.71 percent, Yangzijiang Shipbuilding tumbled 1.84 percent and Wilmar International, Mapletree Logistics Trust, Genting Singapore, DBS Group, CapitaLand Integrated Commercial Trust, SingTel and UOL Group were unchanged.The lead from Wall Street is broadly positive as the major averages opened higher on Tuesday and picked up steam as the day progressed, ending sharply higher.The Dow surged 499.51 points or 1.45 percent to finish at 34,911.20, while the NASDAQ soared 287.30 points or 2.15 percent to end at 13,619.66 and the S&P 500 jumped 70.52 points or 1.61 percent to close at 4,462.21.The rally on Wall Street reflected largely upbeat earnings news from companies like Hasbro (HAS) and Johnson & Johnson (JNJ), although insurance giant Travelers (TRV) moved sharply lower despite earnings that beat estimates.In U.S. economic news, the Commerce Department said new residential construction saw modest growth in March, while building permits also unexpectedly bounced higher.Crude oil prices fell sharply Tuesday on concerns about outlook for energy demand following a downward revision in global growth forecast by the International Monetary Fund. West Texas Intermediate Crude oil futures for May ended down by $5.65 or 5.2 percent at $102.56 a barrel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
